Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Desterke, Christophe  [Clear All Filters]
2024
Chaker D, Desterke C, Moniaux N, Bani M-A, Oudrhiri N, Faivre J, Turhan AG, Bennaceur-Griscelli A, Griscelli F. Direct reprogramming of hepatocytes into JAK/Stat-dependent LGR5+ liver cells able to initiate intrahepatic cholangiocarcinoma. Stem Cells. 2024.
2023
Baykal-Köse S, Voldoire M, Desterke C, Sorel N, Cayssials E, Johnson-Ansah H, Guerci-Bresler A, Bennaceur-Griscelli A, Chomel J-C, Turhan AG. ENOX2 NADH Oxidase: A BCR-ABL1-dependent Cell Surface and Secreted Redox Protein in Chronic Myeloid Leukemia (CML). Turk J Haematol. 2023.
Marcoux P, Imeri J, Desterke C, Latsis T, Chaker D, Hugues P, Griscelli ABennaceur, Turhan AG. Impact of the overexpression of the tyrosine kinase receptor (RET) in the hematopoietic potential of induced pluripotent stem cells (iPSCs). Cytotherapy. 2023.
Malham VBou, Benzoubir N, Vaquero J, Desterke C, Agnetti J, Song PXuan, Gonzalez-Sanchez E, Arbelaiz A, Jacques S, Di Valentin E, et al. Intrinsic cancer cell phosphoinositide 3-kinase δ regulates fibrosis and vascular development in cholangiocarcinoma. Liver Int. 2023.
Cosialls E, Pacreau E, Duruel C, Ceccacci S, Elhage R, Desterke C, Roger K, Guerrera C, Ducloux R, Souquere S, et al. mTOR inhibition suppresses salinomycin-induced ferroptosis in breast cancer stem cells by ironing out mitochondrial dysfunctions. Cell Death Dis. 2023;14(11):744.
2021
Turhan AG, Hwang JW, Chaker D, Tasteyre A, Latsis T, Griscelli F, Desterke C, Bennaceur-Griscelli A. iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology. Front Med (Lausanne). 2021;8:728543.
2020
Zhang Y, Devocelle A, Souza L, Foudi A, Bento STenreira, Desterke C, Sherrard R, Ballesta A, Adam R, Giron-Michel J, et al. BMAL1 knockdown triggers different colon carcinoma cell fates by altering the delicate equilibrium between AKT/mTOR and P53/P21 pathways. Aging (Albany NY). 2020;12.
Desterke C, Petit L, Sella N, Chevallier N, Cabeli V, Coquelin L, Durand C, Oostendorp RAJ, Isambert H, Jaffredo T, et al. Inferring Gene Networks in Bone Marrow Hematopoietic Stem Cell-Supporting Stromal Niche Populations. iScience. 2020;23(6):101222.
Hwang JWook, Loisel-Duwattez J, Desterke C, Latsis T, Pagliaro S, Griscelli F, Bennaceur-Griscelli A, Turhan AG. A novel neuronal organoid model mimicking glioblastoma (GBM) features from induced pluripotent stem cells (iPSC). Biochim Biophys Acta Gen Subj. 2020:129540.
2019
Sidahmed-Adrar N, Ottavi J-F, Benzoubir N, Saadi TAit, Saleh MBou, Mauduit P, Guettier C, Desterke C, Le Naour F. Tspan15 is a New Stemness-Related Marker in Hepatocellular Carcinoma. Proteomics. 2019:e1900025.
2018
Gentil M, Hugues P, Desterke C, Telliam G, Sloma I, Souza LEB, Baykal S, Artus J, Griscelli F, Guerci A, et al. Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML). PLoS One. 2018;13(8):e0200923.
2015
Benzoubir N, Mussini C, Lejamtel C, Santos ADos, Guillaume C, Desterke C, Samuel D, Bréchot C, Bourgeade M-F, Guettier C. Gamma-Smooth Muscle Actin Expression Is Associated with Epithelial-Mesenchymal Transition and Stem-Like Properties in Hepatocellular Carcinoma. PLoS One. 2015;10(6):e0130559.
Desterke C, Martinaud C, Guerton B, Pieri L, Bogani C, Clay D, Torossian F, Lataillade J-J, Hasselbalch HC, Gisslinger H, et al. The tetraspanin CD9 participates in dysmegakaryopoiesis and in stroma interactions in primary myelofibrosis. Haematologica. 2015.
2014
Dianat N, Dubois-Pot-Schneider H, Steichen C, Desterke C, Leclerc P, Raveux A, Combettes L, Weber A, Corlu A, Dubart-Kupperschmitt A. Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells. Hepatology. 2014.